Nanovaccines silencing IL-10 production at priming phase for boosting immune responses to melanoma

Pre- and Post-Transcriptional Regulation of cFLIP for Effective Cancer Therapy Using pH-Ultrasensitive Nanoparticles

(2021) Cao Dai Phung et al.   ACS Applied Materials & Interfaces

Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review

(2020) Cao Dai Phung et al.   ARCHIVES OF PHARMACAL RESEARCH

Recent progress of graphene oxide as a potential vaccine carrier and adjuvant

(2020) Wanjun Cao et al.   Acta Biomaterialia

Anti-CTLA-4 Antibody-Functionalized Dendritic Cell-derived Exosomes Targeting Tumor-draining Lymph Nodes for Effective Induction of Antitumor T-cell Responses

(2020) Cao Dai Phung et al.   Acta Biomaterialia

Engineered Cell‐Membrane‐Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity

(2020) Yao Jiang et al.   ADVANCED MATERIALS

PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer

(2020) Cao Dai Phung et al.   PHARMACEUTICAL RESEARCH

Tumor cell membrane enveloped aluminum phosphate nanoparticles for enhanced cancer vaccination

(2020) Jingyao Gan et al.   JOURNAL OF CONTROLLED RELEASE

DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine

(2020) Rui Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Turning the corner on therapeutic cancer vaccines

(2019) Robert E. Hollingsworth et al.   npj Vaccines

Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses

(2019) Md Hossain et al.   Cancers

Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy

(2019) Tuan Hiep Tran et al.   Acta Biomaterialia

Transferrin-conjugated pH-sensitive platform for effective delivery of porous palladium nanoparticles and paclitaxel in cancer treatment

(2019) Hanh Thuy Nguyen et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Method for the Instant In-Flight Manufacture of Black Phosphorus to Assemble Core@Shell Nanocomposites for Targeted Photoimmunotherapy

(2019) Hanh Thuy Nguyen et al.   ACS Applied Materials & Interfaces

MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer

(2019) Parvin Zamani et al.   JOURNAL OF CONTROLLED RELEASE

Regulatory T Cells Tailored with pH-Responsive Liposomes Shape an Immuno-Antitumor Milieu against Tumors

(2019) Wenquan Ou et al.   ACS Applied Materials & Interfaces

Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine

(2019) Naho Tateshita et al.   JOURNAL OF CONTROLLED RELEASE

Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis

(2019) Mengying Hu et al.   JOURNAL OF CONTROLLED RELEASE

Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death

(2019) Cao Dai Phung et al.   JOURNAL OF CONTROLLED RELEASE

Necroptotic cancer cells-mimicry nanovaccine boosts anti-tumor immunity with tailored immune-stimulatory modality

(2018) Ting Kang et al.   BIOMATERIALS

Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy

(2018) Zar Chi Soe et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Nanoparticles for dendritic cell-based immunotherapy

(2018) Tuan Hiep Tran et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy

(2018) Wenquan Ou et al.   JOURNAL OF CONTROLLED RELEASE

Fully Artificial Exosomes: Towards New Theranostic Biomaterials

(2018) Pablo García-Manrique et al.   TRENDS IN BIOTECHNOLOGY

Targeting Toll-Like Receptors for Cancer Therapy

(2018) Marc J. Braunstein et al.   Targeted Oncology

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10

(2018) Diana Llopiz et al.   Frontiers in Immunology

Rational combination immunotherapeutic approaches for effective cancer treatment

(2018) Cao Dai Phung et al.   JOURNAL OF CONTROLLED RELEASE

Biomaterials for vaccine-based cancer immunotherapy

(2018) Rui Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Staphylococcus aureus-mimetic control of antibody orientation on nanoparticles

(2018) Gayong Shim et al.   Nanomedicine-Nanotechnology Biology and Medicine

Defining Memory CD8 T Cell

(2018) Matthew D. Martin et al.   Frontiers in Immunology

Synthetic nanovaccines for immunotherapy

(2017) Min Luo et al.   JOURNAL OF CONTROLLED RELEASE

Therapeutic Antibodies against Intracellular Tumor Antigens

(2017) Iva Trenevska et al.   Frontiers in Immunology

IL-10 Regulates Memory T Cell Development and the Balance between Th1 and Follicular Th Cell Responses during an Acute Viral Infection

(2016) Yuan Tian et al.   JOURNAL OF IMMUNOLOGY

Biomimetic proteolipid vesicles for targeting inflamed tissues

(2016) R. Molinaro et al.   NATURE MATERIALS

Keratin mediates the recognition of apoptotic and necrotic cells through dendritic cell receptor DEC205/CD205

(2016) Longxing Cao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

NK cells activated by Interleukin-4 in cooperation with Interleukin-15 exhibit distinctive characteristics

(2016) Tsuyoshi Kiniwa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer immunotherapy targeting neoantigens

(2016) Yong-Chen Lu et al.   SEMINARS IN IMMUNOLOGY

The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8+T cell immunity

(2015) Y.-H. Ahn et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

How Do Cytotoxic Lymphocytes Kill Cancer Cells?

(2015) L. Martinez-Lostao et al.   CLINICAL CANCER RESEARCH

T cell subsets and their signature cytokines in autoimmune and inflammatory diseases

(2015) Itay Raphael et al.   CYTOKINE

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Human Tumor Antigens and Cancer Immunotherapy

(2015) Nathalie Vigneron   Biomed Research International

The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma

(2014) Pallab Pradhan et al.   BIOMATERIALS

Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study

(2014) Luis J. Cruz et al.   JOURNAL OF CONTROLLED RELEASE

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

(2014) Ronnie H. Fang et al.   NANO LETTERS

IL-10 Suppression of NK/DC Crosstalk Leads to Poor Priming of MCMV-Specific CD4 T Cells and Prolonged MCMV Persistence

(2012) Sanja Mandaric et al.   PLoS Pathogens

Trial watch

(2012) Erika Vacchelli et al.   OncoImmunology

Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A

(2011) J. Idoyaga et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes

(2010) K. Movahedi et al.   CANCER RESEARCH

IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection

(2010) Galit Alter et al.   JOURNAL OF CLINICAL INVESTIGATION

Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN- , and IL-17A by Naive CD4+ T Cells

(2009) V. Lombardi et al.   JOURNAL OF IMMUNOLOGY

CD205 (DEC-205): A recognition receptor for apoptotic and necrotic self

(2009) Rachel E. Shrimpton et al.   MOLECULAR IMMUNOLOGY

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis

(2009) Masako Murai et al.   NATURE IMMUNOLOGY

Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-127–35

(2008) Arvind Chhabra et al.   CLINICAL IMMUNOLOGY